- Home
- ULS vs ICLR Comparison
ULS vs ICLR Comparison
Compare ULS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULS
- ICLR
- Stock Information
- Founded
- ULS 1894
- ICLR 1990
- Country
- ULS United States
- ICLR Ireland
- Employees
- ULS N/A
- ICLR N/A
- Industry
- ULS
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ULS
- ICLR Health Care
- Exchange
- ULS Nasdaq
- ICLR Nasdaq
- Market Cap
- ULS 14.6B
- ICLR 13.7B
- IPO Year
- ULS 2024
- ICLR 1998
- Fundamental
- Price
- ULS $63.92
- ICLR $177.81
- Analyst Decision
- ULS Buy
- ICLR Buy
- Analyst Count
- ULS 8
- ICLR 14
- Target Price
- ULS $69.25
- ICLR $212.62
- AVG Volume (30 Days)
- ULS 949.4K
- ICLR 956.9K
- Earning Date
- ULS 11-04-2025
- ICLR 10-22-2025
- Dividend Yield
- ULS 0.81%
- ICLR N/A
- EPS Growth
- ULS 21.42
- ICLR 13.11
- EPS
- ULS 1.62
- ICLR 9.73
- Revenue
- ULS $2,951,000,000.00
- ICLR $8,089,820,000.00
- Revenue This Year
- ULS $6.69
- ICLR N/A
- Revenue Next Year
- ULS $6.24
- ICLR $1.73
- P/E Ratio
- ULS $39.53
- ICLR $17.96
- Revenue Growth
- ULS 6.92
- ICLR N/A
- 52 Week Low
- ULS $46.79
- ICLR $125.10
- 52 Week High
- ULS $74.15
- ICLR $310.54
- Technical
- Relative Strength Index (RSI)
- ULS 41.99
- ICLR 57.19
- Support Level
- ULS $62.20
- ICLR $161.01
- Resistance Level
- ULS $64.44
- ICLR $180.95
- Average True Range (ATR)
- ULS 1.64
- ICLR 5.65
- MACD
- ULS 0.07
- ICLR -0.49
- Stochastic Oscillator
- ULS 38.91
- ICLR 77.56
About ULS UL Solutions Inc.
UL Solutions is a global leader specializing in a broad range of product testing, inspection, and certification services. UL Solutions is the for-profit branch out of three organizations under the UL Enterprise. TIC operations make up nearly all of UL Solutions' total revenue and are composed of two segments: industrial and consumer. UL Solutions' remaining business includes software and advisory, which complements its core TIC offerings. The firm operates globally.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.